The announcement comes a week after Amgen said it would cut 149 jobs, or a quarter of its staff, at its Kendall Square location in Cambridge, Mass.
The cuts will mostly affect operations, research and development, and field-based commercial positions.
The final number of cuts may be lower than 172, as some employees are being offered other jobs within Amgen, according to Endpoints News.
The layoffs are expected to begin Dec. 31.
Read the full article here.
More articles on pharmacy:
AHA, CVS Health backed secretive anti-pharma group
EpiPen, Humira among drugs Warren wants to regulate
31 drugmakers at high risk for bankruptcy in 2020
